Summit State Bank Reports Net Income for First Quarter 2017 and Declaration of Dividend
Apr 25, 2017 13:02 pm UTC| Business
SANTA ROSA, Calif., April 25, 2017 -- Summit State Bank (Nasdaq:SSBI) today reported net income for the quarter ended March 31, 2017 of $881,000 and diluted earnings per share of $0.15. A quarterly dividend of $0.12 per...
TaskEasy To Moderate Yard Care Panel at IMN Rental Forum East
Apr 25, 2017 13:01 pm UTC| Business
SALT LAKE CITY, April 25, 2017 -- TaskEasy, Inc., the leading nationwide, on-demand yard maintenance provider, will moderate a panel with other major companies in the single family rental industry at the upcoming IMN...
TaskEasy To Moderate Yard Care Panel at IMN Rental Forum East
Apr 25, 2017 13:01 pm UTC| Business
SALT LAKE CITY, April 25, 2017 -- TaskEasy, Inc., the leading nationwide, on-demand yard maintenance provider, will moderate a panel with other major companies in the single family rental industry at the upcoming IMN...
Xplore Expands Price and Performance Range of Category-Leading XSLATE R12 Rugged Tablet Portfolio
Apr 25, 2017 13:01 pm UTC| Business
AUSTIN, Texas, April 25, 2017 -- Xplore Technologies Corp. (NASDAQ:XPLR) is expanding the pricing and performance options for its highly-demanded XSLATE R12 rugged tablet PC platform in order to accommodate customers’...
Xplore Expands Price and Performance Range of Category-Leading XSLATE R12 Rugged Tablet Portfolio
Apr 25, 2017 13:01 pm UTC| Business
AUSTIN, Texas, April 25, 2017 -- Xplore Technologies Corp. (NASDAQ:XPLR) is expanding the pricing and performance options for its highly-demanded XSLATE R12 rugged tablet PC platform in order to accommodate customers’...
Apr 25, 2017 13:01 pm UTC| Business
FREMONT, Calif., April 25, 2017 -- Sigma Designs® (NASDAQ:SIGM), a leading provider of intelligent system-on-chip (SoC) solutions for Connected Smart TV Platforms and Internet of Things (IoT) Devices, announced that...
Apr 25, 2017 13:01 pm UTC| Business
MALVERN, Pa., April 25, 2017 -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biopolymer-based drugs for the treatment of orphan diseases with an initial focus on cardiopulmonary...